A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer

NCT01163929 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Study closed by Protocol Review Monitoring Committee because of lack of accrual

Conditions

Interventions

Sponsor

University of Kansas

Collaborators